Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.1K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.1K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

388
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
388
Lipids as Anchors01:32

Lipids as Anchors

6.5K
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
6.5K
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

5.7K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
5.7K
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

200
Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin,...
200
What are Lipids?01:38

What are Lipids?

214.1K
Overview
214.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of low lipoprotein(a) levels: the FOURIER trial.

European heart journal·2026
Same author

Nonlinearity of the inverse relationship between high-density lipoprotein (HDL) cholesterol and incident cardiovascular risk: Is it time to revisit the "HDL hypothesis"?

Journal of clinical lipidology·2025
Same author

The role of nutrition-related clinical trials in informing dietary recommendations for health and treatment of diseases.

Journal of clinical lipidology·2024
Same author

Niacin, food intake and cardiovascular effects.

Nature medicine·2024
Same author

Beyond the Methods: Economic Stability and Cardiovascular Health.

Circulation. Cardiovascular quality and outcomes·2024
Same author

JCL roundtable: Evolution of preventive cardiology and clinical lipidology.

Journal of clinical lipidology·2024

Related Experiment Video

Updated: Nov 1, 2025

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.9K

JCL Roundtable: Global Think Tank on Lipoprotein(a).

Lisa L Maher1, S Lale Tokgözoğlu2, Eduardo J Sanchez3

  • 1Cedar Valley Cardiovascular Center, Waterloo, IA, USA.

Journal of Clinical Lipidology
|June 19, 2021
PubMed
Summary

Lipoprotein(a) significantly increases cardiovascular risk for 20% of people. New therapies show promise for reducing levels and cardiovascular events, necessitating global standardization and education.

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.5K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

Related Experiment Videos

Last Updated: Nov 1, 2025

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.9K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.5K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Pharmacology

Background:

  • Lipoprotein(a) is a causal factor in atherosclerosis, arterial thrombosis, and aortic stenosis.
  • Inherited variations in Lipoprotein(a) levels elevate cardiovascular risk in 20% of the global population.
  • Existing treatments offer limited Lipoprotein(a) reduction (20-30%) without proven cardiovascular risk reduction.

Purpose of the Study:

  • To highlight the growing recognition of Lipoprotein(a)-associated cardiovascular risk.
  • To emphasize the need for standardized laboratory measurements (nmol/L).
  • To discuss emerging therapies and the call for global action.

Main Methods:

  • Review of current understanding of Lipoprotein(a) in cardiovascular disease.
  • Analysis of recent expert consensus and recommendations (e.g., Global Think Tank).
  • Evaluation of existing and novel therapeutic approaches targeting Lipoprotein(a).

Main Results:

  • A consensus was reached on standardizing Lipoprotein(a) measurement in nanomoles per liter.
  • Atherosclerotic risk correlates linearly with plasma Lipoprotein(a) levels.
  • Novel mRNA-targeting therapies demonstrate potential for 80-90% Lipoprotein(a) reduction.

Conclusions:

  • There is a growing mandate for unified global efforts in education, standardization, and clinical management of Lipoprotein(a).
  • Emerging therapies, including antisense oligonucleotides, are under investigation in cardiovascular outcomes trials.
  • Universal screening is recommended by some international cardiovascular societies, but not yet by U.S. organizations.